Add BrightSurf on Google Email

First guidelines from the American Thyroid Associationn: Managing thyroid nodules and cancer in children

The new guidelines provide a broader scope of therapeutic options for pediatric patients with differentiated thyroid cancer, aiming to limit aggressive therapy when it's unlikely to offer benefit. The guidelines specifically address the differences in biological behavior and management of these entities in children.

Childhood cancer survivors more likely to claim social security support as adults

A recent study from Huntsman Cancer Institute found that childhood cancer survivors are more than five times as likely to be enrolled in federal social security disability assistance programs compared to individuals without a cancer history. The study identified survivor socio-demographic and treatment characteristics associated with a...

SourceUniversity of Utah Health·JournalJNCI Journal of the National Cancer Institute·DateApr 21, 2015

Imaging immunity

A novel approach harnessing positron emission tomography (PET) imaging identifies areas of immune cell activity associated with inflammation or tumor development. This method offers a potential breakthrough in diagnostics and monitoring efficacy of cancer therapies.

SourceWhitehead Institute for Biomedical Research·JournalProceedings of the National Academy of Sciences·DateApr 20, 2015

Cancer-related PTS linked to very limited cognitive impairment among newly diagnosed breast cancer patients

A new study found that cancer-related post-traumatic stress is associated with very limited cognitive impairment before treatment among newly diagnosed breast cancer patients. The study, published in the JNCI Journal of the National Cancer Institute, analyzed data from 166 breast cancer patients and 60 matched controls.

SourceOxford University Press USA·JournalJNCI Journal of the National Cancer Institute·DateApr 16, 2015

Migrating immune cells promote nerve cell demise in the brain

Researchers found that inflammatory cells from the bloodstream play a key role in neurodegeneration in Parkinson's disease. CD95L-bearing immune cells cause damage to neurons, and blocking this molecule can prevent neurodegeneration in mice. This suggests that early treatment with drugs targeting CD95L might mitigate Parkinson's symptoms.

Integrative approaches key to understanding cancer, developing therapies, say Moffitt scientists

Moffitt scientists are using a new theory called the Big Bang model of cancer heterogeneity, which suggests that mutations occur early during tumor development. This approach has significant implications for treatments, as it recognizes that tumors can change during treatment and that current therapeutic approaches ignore this fact.

Predicting prostate cancer

Researchers developed a nanotechnology-based method to assess prostate cancer risk, enabling doctors to identify aggressive forms of the disease and tailor treatment recommendations. The study's findings suggest that this approach may improve patient outcomes by minimizing side effects.

SourceNorthwestern University·JournalPLOS ONE·DateMar 16, 2015

New possibilities for the treatment of breast cancer arise, with the help of mathematics

A Swiss Institute of Bioinformatics-led trial demonstrates the potential of mathematical modelisation and experimentation in treating breast cancer. By combining clinical and experimental oncology with modelisation, researchers identified mechanisms that enable tumour cells to shape monocyte activities for their advantage.

SourceSwiss Institute of Bioinformatics·JournalPLOS Computational Biology·DateMar 16, 2015

Immune system-in-a-dish offers hope for 'bubble boy' disease

Researchers at Salk Institute have developed a new method to convert cells from x-linked SCID patients into stem cell-like state, fix the genetic mutation and prompt corrected cells to successfully generate NK cells in the laboratory. This technique could lead to a more effective and less invasive treatment for this devastating disease.

SourceSalk Institute·JournalCell Stem Cell·DateMar 12, 2015

Understanding how the stomach responds to injury could help target therapy against gastric damage

Researchers have found that IL-33 is a critical messenger triggering changes in the stomach's inflammatory response to H. pylori infection, potentially leading to new therapies targeting gastric damage. Elevated IL-33 levels may be associated with chronic infection and metaplasia.

SourceAmerican Gastroenterological Association·JournalCellular and Molecular Gastroenterology and Hepatology·DateMar 5, 2015